| | To ensure that you never miss an issue, please whitelist us. |
|
|
| | | Diabetes is a chronic medical condition that affects millions of people around the world. The disease is characterized by elevated levels of glucose in the blood, which is caused by the body’s inability to properly use insulin. While diabetes is typically known for its effects on blood sugar levels, it can also increase the risk of developing cardiovascular disease (CVD). In this article, we will examine the relationship between diabetes and CVD, and who is most at risk for developing these conditions. |
|
|
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of medications that have been developed to treat type 2 diabetes. SGLT2 inhibitors work by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine and improved glucose control. The continued benefits of SGLT2 inhibitors in the treatment of type 2 diabetes have been well established in numerous clinical trials and real-world studies. |
| | |
| |
| |
Diabetes is a chronic health condition that affects millions of people in the United States, and its impact can vary depending on the region in which a person lives. The American Diabetes Association (ADA) is a non-profit organization dedicated to improving the lives of people with diabetes. In this article, we’ll explore how diabetes affects different regions of the United States and the impact it has on healthcare spending, prognosis, healthcare providers, and resources in these regions. |
| | |
|
|
|
